5 research outputs found

    Directed evolution of CRISPR-Cas9 to increase its specificity

    Get PDF
    The use of CRISPR-Cas9 as a therapeutic reagent is hampered by its off-target effects. Although rationally designed S. pyogenes Cas9 (SpCas9) variants that display higher specificities than the wild-type SpCas9 protein are available, these attenuated Cas9 variants are often poorly efficient in human cells. Here, we develop a directed evolution approach in E. coli to obtain Sniper-Cas9, which shows high specificities without killing on-target activities in human cells. Unlike other engineered Cas9 variants, Sniper-Cas9 shows WT-level on-target activities with extended or truncated sgRNAs with further reduced off-target activities and works well in a preassembled ribonucleoprotein (RNP) format to allow DNA-free genome editing.

    Directed evolution of CRISPR-Cas9 to increase its specificity

    Get PDF
    The use of CRISPR-Cas9 as a therapeutic reagent is hampered by its off-target effects. Although rationally designed S. pyogenes Cas9 (SpCas9) variants that display higher specificities than the wild-type SpCas9 protein are available, these attenuated Cas9 variants are often poorly efficient in human cells. Here, we develop a directed evolution approach in E. coli to obtain Sniper-Cas9, which shows high specificities without killing on-target activities in human cells. Unlike other engineered Cas9 variants, Sniper-Cas9 shows WT-level on-target activities with extended or truncated sgRNAs with further reduced off-target activities and works well in a preassembled ribonucleoprotein (RNP) format to allow DNA-free genome editing. © 2018, The Author(s

    MHC Class I Enables MSCs to Evade NK-Cell-Mediated Cytotoxicity and Exert Immunosuppressive Activity

    No full text
    Allogeneic mesenchymal stem/stromal cells (MSCs) are frequently used in clinical trials due to their low expression of major histocompatibility complex (MHC) class I and lack of MHC class II. However, the levels of MHC classes I and II in MSCs are increased by inflammatory stimuli, raising concerns over potential adverse effects associated with allogeneic cell therapy. Also, it is unclear how the host immune response to MHC-mismatched MSCs affects the therapeutic efficacy of the cells. Herein, using strategies to manipulate MHC genes in human bone marrow-derived MSCs via the CRISPR-Cas9 system, plasmids, or siRNAs, we found that inhibition of MHC class I-not MHC class II-in MSCs lowered the survival rate of MSCs and their immunosuppressive potency in mice with experimental autoimmune uveoretinitis, specifically by increasing MSC vulnerability to natural killer (NK)-cell-mediated cytotoxicity. A subsequent survey of MSC batches derived from 6 human donors confirmed a significant correlation between MSC survival rate and susceptibility to NK cells with the potency of MSCs to increase MHC class I level upon stimulation. Our overall results demonstrate that MHC class I enables MSCs to evade NK-cell-mediated cytotoxicity and exert immunosuppressive activity.Y

    Empirical Approach—Introduction

    No full text
    In this chapter, we will describe the fundamentals of the proposed new “empirical” approach as a systematic methodology with its nonparametric quantities derived entirely from the actual data with no subjective and/or problem-specific assumptions made. It has a potential to be a powerful extension of (and/or alternative to) the traditional probability theory, statistical learning and computational intelligence methods. The nonparametric quantities of the proposed new empirical approach include: (1) the cumulative proximity; (2) the eccentricity, and the standardized eccentricity; (3) the data density, and (4) the typicality. They can be recursively updated on a sample-by-sample basis, and they have unimodal and multimodal, discrete and continuous forms/versions. The nonparametric quantities are based on ensemble properties of the data and not limited by prior restrictive assumptions. The discrete version of the typicality resembles the unimodal probability density function, but is in a discrete form. The discrete multimodal typicality resembles the probability mass function
    corecore